IO360° Strategic Advisors
IO360° Founding Advisors
Axel Hoos, MD, PhD
Former CEO, Scorpion Therapeutics
James Gulley, MD, PhD
Co-Director, Center for Immuno-Oncology, CCR & Clinical Director,
National Cancer Institute
Industry Advisors
Rick Aldridge, MBChB
Managing Director, Healthcare Investment Banking
Michael Kalos, PhD
Managing Director, Next Pillar Consulting
Andrew Baum, MD
Chief Strategy and Innovation Officer, Pfizer
Theresa LaVallee, PhD
Chief Development Officer, Coherus BioSciences
Jeffrey Bockman, PhD
EVP & Expert Advisor, Oncology, Head of Oncology Center of Excellence, Lumanity
David Leung, MD, PhD
Head of Imaging, Daiichi Sankyo
Daniel Chen, MD, PhD
Founder & CEO, Synthetic Design Lab
Jayant Narang, MD
Sr Medical Director, Clinical Oncology Imaging Lead, Preclinical and Translational Sciences, Takeda Pharmaceuticals
Charles Drake, MD, PhD
VP, Immuno-Oncology, J&J Innovative Medicine
Rosanna Ricafort, MD
VP and Head, Hematology and Cellular Therapy Development, BMS
Hanif Gabrani-Juma, BEng, MASc
Associate Director, Translational Medicine Strategy, Radiology Imaging & AI, Oncology R&D Cancer Biomarker Development, AstraZeneca
Zhen Su, MD, MBA
CEO & Director, Marengo
Diederik Grootendorst, PhD
Director, Global Oncology, Imaging
Graig C Suvannavejh, PhD
Managing Director, Equity Research Biopharmaceuticals & Biotechnology, Mizuho Securities USA
Gregory Frank, PhD
Global Scientific Partnering Strategy, Immuno-Oncology, GE Healthcare
Alex Snyder, MD
Head, R&D, Generate Biomedicines
Greg Goldmacher, MD, PhD, MBA
Associate VP, Clinical Research, Head, Clinical Imaging & Pathology,
Merck Research Labs
Leon “Jun” Tang, PhD
Founder, InScienceWeTrust BioAdvisory
Asthika Goonewardene, MBA
Managing Director, Senior Biotech Analyst, Truist Securities
Raluca Verona, PhD
Head, Oncology Precision Medicine Group, AbbVie
Priti Hegde, PhD
SVP & Global Head of Research, Kite Pharma, a Gilead Company
Wim Vos, PhD
CEO, Radiomics.bio
Catherine Hines, PhD
Executive Director and Head, Clinical Imaging, GSK
Sarah Warren, PhD
Sr Director, Corporate Development Lead, Cell Therapy Search and Evaluation, Kite Pharma, a Gilead Company
William Ho, MBA
President & CEO, In8Bio
-
-
2026 Sponsors
